Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00180947

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Neoplasms, Connective and Soft Tissue Clinical Trial

Official title:
Phase II Study of Vinorelbine + Cyclofosfamide Association Among Patients Reached of Refractory Tumours or in Relapse

Clinical Trial Summary

This is a phase II study to determine the antitumor activity of Vinorelbine and Cyclofosfamide association among patients with refractory tumours or in relapse with rhabdomyosarcomas and other soft tissue tumours, Ewing tumours, osteosarcomas, neuroblastomas or medulloblastomas.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00180947
Study type Interventional
Source Gustave Roussy, Cancer Campus, Grand Paris
Contact Odile OBERLIN, MD
Phone 33 1 42 11 41 74
Email oberlin@igr.fr
Status Recruiting
Phase Phase 2
Start date June 2003
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04910126 - Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma Phase 2
Enrolling by invitation NCT01883518 - Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma Phase 1/Phase 2
Recruiting NCT04960332 - Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall. N/A
Recruiting NCT02677961 - An Electronic Health Record (EHR)-Based Comprehensive Bone and Soft Tissue Tumor Registry
Terminated NCT05160168 - A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) Phase 1/Phase 2
Recruiting NCT05440240 - Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture Phase 4
Recruiting NCT05057130 - Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors Phase 2/Phase 3
Terminated NCT03495921 - A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide Phase 3
Terminated NCT01491594 - Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia Phase 1
Completed NCT00102609 - A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma Phase 1